Abbott Laboratories (Philippines), Inc.

DUBLIN, Feb. 23, 2023 /PRNewswire/ -- The "Kidney Function Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Urine Tests, Blood Tests), By Component (Dipsticks, Reagents, Kits & Assays, Others), By End User, By Region" report has been added to ResearchAndMarkets.com's offering. The global kidney function tests market was valued over USD 862 million in 2022 and is forecast to grow at a CAGR of 9.71% through 2028. Companies Mentioned Baxter International Inc Abbott Laboratories, Inc. Sysmex Corporation F. Hoffmann-La Roche Ltd Danaher Corporation URIT Medical Electronic Co. Ltd Nova Biomedical Corporation Laboratory Corporation of America Holdings Siemens Healthineers ARKRAY Inc. IDEXX Laboratories, Inc Fresenius SE & Co. KGaA Cook Group ACON Laboratories, Inc. Randox Laboratories Ltd. The growth of the global market for kidney function tests is anticipated to be supported by an increase in awareness of diagnostic techniques for kidney function. The growing global burden of chronic kidney disease is attributed in huge share to diabetes and high blood pressure. In the upcoming years, rising diabetes rates will have an effect on market expansion. The International Diabetes Atlas' tenth edition estimates that 537 million adults (20-79 years old), or one in ten people, had diabetes in 2021. It is anticipated that this number will increase to 643 million by 2030 and 783 million by 2045. Kidneys are among the most vital organs of the human body. Kidneys acts as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the blood. Hence, they require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth, otherwise they become vulnerable to cancerous tumors and metastasis. The functional damage of the kidney is common across the world and its incidents are increasing at a rapid pace. The symptoms which indicate a problem related to kidneys include high blood pressure, blood in urine, difficulty in urination, frequent urges to urinate, and swelling in the hands and feet due to a buildup of fluids in the body. Rising Prevalence of Kidney Disorders and Diseases The growing occurrence of several kidney disorders such as acquired cystic kidney disease, amyloidosis & kidney disease, diabetes insipidus, ectopic kidney, glomerular diseases, anti-GBM (Goodpasture's) disease, IgA nephropathy, among others have drastically increased the number of patients which requires accurate diagnosis and proper treatment. This, in turn, is expected to drive the growth of the global kidney function tests market. Furthermore, acute kidney injury (AKI), also known as acute renal failure or acute kidney injury, is very common in patients who are in hospitals. Acute kidney injury (AKI) affects more than 13 million people and results in 1.7 million deaths every year across the globe. Owing to the rising incidences of kidney diseases and disorders, the demand for early diagnosis and treatments is expected to surge, which bolsters the growth of the market. For instance, according to the Centers for Disease Control and Prevention (CDC), 40% of people with rigorously reduced kidney function are not aware of having chronic kidney disease (CKD). Technological Advancements Rising adoption of advanced technology concerning diagnosis and treatment is expected to bolster the growth of the market. These continuous developments and innovations are providing better treatments to patients. The latest trends in technology are using computer-based intelligent decision support systems (DSS) and expert systems, which are used in dialysis and are based on genetic algorithms and artificial neural networks (ANN). Also, the increase in interest in the internet of things (IoT), deep learning, an expanded and complex version of shallow ANN, is being used in the medical field. These advancements help in image diagnosis, alerting systems, and diagnostic assistance. Increase in the Prevalence of Diabetes and Hypertension The growing occurrences of underlying conditions such as diabetes and hypertension among the masses have significantly increased the demand for getting diagnoses and treatments done for these chronic diseases. This, in turn, is expected to positively influence the growth of the global kidney function tests market. According to the Centers for Disease Control and Prevention (CDC), in 2019, there are approximately 37.3 million people who have diabetes, accounting for 11.3% of the US population. Out of these, 28.7 million people are diagnosed, and 8.5 million people are undiagnosed. Rising geriatric population is more prone to kidney diseases and kidney failures as aging increases the risk of chronic diseases such as diabetes and hypertension. The increase in the number of elders suffering from diabetes and hypertension is surging the demand for kidney function tests, as kidney disorders and kidney failures are caused by these chronic diseases. Therefore, owing to the rising prevalence of diabetes and hypertension, there is a surge in the number of cases of Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI), which in turn, is facilitating the growth of the market. Recent Developments In 2019, Fresenius Medical Care received breakthrough device designation by the U.S. FDA for its most recent hemodialysis machine, whose objective is to stop blood clotting without using any medication Similarly, in 2019, CareDx announced the new model built for kidney transplants. It has included Predicted artificial intelligence (AI) for individuals who are suffering from chronic kidney diseases (CKD). Recently, in 2022, bioMerieux received United States Food and Drug Administration (US FDA) authorization for the innovative VIDAS NEPHROCHECK assay to detect kidney stress in individuals who are at risk of acute kidney injury (AKI). Market Players Baxter International Inc., Abbott Laboratories, Inc., Sysmex Corporation., F. Hoffmann-La Roche Ltd., Danaher Corporation., URIT Medical Electronic Co. Ltd., Nova Biomedical Corporation., Laboratory Corporation of America Holdings., Siemens Healthineers., ARKRAY Inc., IDEXX Laboratories, Inc., Fresenius SE & Co. KGaA., Cook Group., ACON Laboratories, Inc, and Randox Laboratories Ltd. are some of the leading companies operating in the market. Report Scope: In this report, global kidney function tests market has been segmented into following categories, in addition to the industry trends which have also been detailed below: Kidney Function Tests Market, By Type: Urine Tests Urine Protein Tests Creatinine Clearance Tests Microalbumin Tests Blood Tests Serum Creatinine Tests Glomerular Filtration Rate Tests Blood Urea Nitrogen Tests Others Kidney Function Tests Market, By Component: Dipsticks Reagents Kits & Assays Others Kidney Function Tests Market, By End User: Hospitals & Clinics Diagnostic Laboratories Others Kidney Function Tests Market, By Region: North America United States Canada Mexico Europe France Germany United Kingdom Netherlands Sweden Italy Spain Asia-Pacific China Japan Singapore India South Korea Australia South America Brazil Argentina Colombia Middle East & Africa UAE Saudi Arabia South Africa For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

DUBLIN--( BUSINESS WIRE )--The "Global Cytology and HPV Testing Market (2022-2027) by Test Type, Application, End-User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Cytology and HPV Testing Market is estimated to be USD 11.05 Bn in 2022 and is expected to reach USD 14.93 Bn by 2027, growing at a CAGR of 6.2% Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks. Competitive Quadrant The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Ansoff Analysis The report presents a detailed Ansoff matrix analysis for the Global Cytology and HPV Testing Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the Global Cytology and HPV Testing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth. Why buy this report? The report offers a comprehensive evaluation of the Global Cytology and HPV Testing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies. The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry. The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report. The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies. The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool. Market Dynamics Drivers Increasing Number of Cervical Cancer Cases and Growing Aging Population Increasing Awareness of Cervical Cancer Screening Programs Restraints Frequent Changes in Regulatory Guidelines for Cervical Cancer Screening Lack of Proper Healthcare Infrastructure Presence of Outdated Facilities in Most of the Developing Countries Opportunities Increasing Investment in Healthcare Industry Worldwide Advancement in Technology and Increasing Government Initiatives and Funding Challenges Limitations Oriented to the Complexities in Diagnosis Market Segmentation The Global Cytology and HPV Testing Market is segmented based on Test Type, Application, End-User, and Geography. By Test Type, the market is classified into HPV Testing and Cytology Testing. By Product Type, the market is classified into Instruments, Consumables, and Services. By Technology Type, the market is classified into Instruments, Consumables, and Services. By Product Type, the market is classified into PCR, Immunodiagnostics, and Other By Application, the market is classified into Cervical Cancer Screening and Vaginal Cancer Screening. By End-User, the market is classified into Laboratories, Hospitals & Clinics, and Physician's Office. By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific. Companies Mentioned Abbott Laboratories, Inc. Agilent Technologies, Inc. Becton, Dickinson & Company CellPath, Ltd. Danaher Corp. F. Hoffmann-La Roche, Ltd. GlaxoSmithKline, PLC Hologic, Inc. Medimeas Merck KGaA Novartis Ag PerkinElmer, Inc. Sysmex Corp. Thermo Fisher Scientific, Inc. Trivitron Healthcare For more information about this report visit https://www.researchandmarkets.com/r/wklvy7

DUBLIN--( BUSINESS WIRE )--The "Coagulation Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Coagulation Testing Market to Reach $3.8 Billion by 2027 In the changed post COVID-19 business landscape, the global market for Coagulation Testing estimated at US$2.7 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 5.1% CAGR and reach US$3.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 3.7% CAGR for the next 7-year period. The U.S. Market is Estimated at $742.5 Million, While China is Forecast to Grow at 7.2% CAGR The Coagulation Testing market in the U.S. is estimated at US$742.5 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$778.1 Million by the year 2027 trailing a CAGR of 7.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR. Select Competitors (Total 38 Featured) - Abbott Laboratories, Inc. Agappe Diagnostics Ltd. Alere, Inc. F. Hoffmann-La Roche AG Helena Laboratories, Inc. HemoSonics, LLC Horiba, Ltd. Medtronic PLC Randox Laboratories Ltd. Siemens Healthineers Sysmex Corporation Thermo Fisher Scientific, Inc. Universal Biosensors Inc. Key Topics Covered: I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE III. MARKET ANALYSIS IV. COMPETITION For more information about this report visit https://www.researchandmarkets.com/r/82myiu